HomeCompareMLBEF vs MRK

MLBEF vs MRK: Dividend Comparison 2026

MLBEF yields 5000.00% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MLBEF wins by $566.53M in total portfolio value
10 years
MLBEF
MLBEF
● Live price
5000.00%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$566.59M
Annual income
$13,723,006.45
Full MLBEF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — MLBEF vs MRK

📍 MLBEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMLBEFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MLBEF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MLBEF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MLBEF
Annual income on $10K today (after 15% tax)
$425,000.00/yr
After 10yr DRIP, annual income (after tax)
$11,664,555.48/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MLBEF beats the other by $11,655,958.77/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MLBEF + MRK for your $10,000?

MLBEF: 50%MRK: 50%
100% MRK50/50100% MLBEF
Portfolio after 10yr
$283.32M
Annual income
$6,866,560.11/yr
Blended yield
2.42%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MLBEF
No analyst data
Altman Z
0.5
Piotroski
4/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MLBEF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMLBEFMRK
Forward yield5000.00%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$566.59M$57.7K
Annual income after 10y$13,723,006.45$10,113.78
Total dividends collected$431.41M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MLBEF vs MRK ($10,000, DRIP)

YearMLBEF PortfolioMLBEF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$260,700$250,000.00$11,213$373.04+$249.5KMLBEF
2$3,324,510$3,045,560.75$12,667$512.06+$3.31MMLBEF
3$21,705,698$18,148,472.29$14,439$708.14+$21.69MMLBEF
4$78,594,831$55,369,734.26$16,640$988.16+$78.58MMLBEF
5$177,783,375$93,686,906.45$19,432$1,394.07+$177.76MMLBEF
6$289,257,188$99,028,976.26$23,057$1,992.90+$289.23MMLBEF
7$384,795,925$75,290,733.55$27,889$2,894.79+$384.77MMLBEF
8$458,534,679$46,803,039.60$34,518$4,286.29+$458.50MMLBEF
9$516,693,763$26,061,656.05$43,912$6,494.35+$516.65MMLBEF
10$566,585,332$13,723,006.45$57,714$10,113.78+$566.53MMLBEF

MLBEF vs MRK: Complete Analysis 2026

MLBEFStock

Webcentral Limited, a digital services company, provides cloud enabling solutions in Australia and New Zealand. The company offers data connectivity, cloud and data center, and managed services. It provides cloud-based solutions and network services; and operates fiber and wireless infrastructure, management of cloud computing environment, and data center facilities. In addition, the company engages in domain name registrations and renewals, website and email hosting, website development, search engine marketing, and social advertising campaigns for businesses. It serves small and medium businesses, enterprises, and wholesale and government customers. The company was formerly known as Webcentral Group Limited and changed its name to Webcentral Limited in November 2021. Webcentral Limited was incorporated in 1996 and is headquartered in Melbourne, Australia.

Full MLBEF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MLBEF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MLBEF vs SCHDMLBEF vs JEPIMLBEF vs OMLBEF vs KOMLBEF vs MAINMLBEF vs JNJMLBEF vs ABBVMLBEF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.